Add time:07/14/2019         Source:sciencedirect.com

A series of N-(2-(1H-imidazol-1-yl)-2-phenylethyl)arylamides were prepared, using an efficient three- to five-step synthesis, and evaluated for their inhibitory activity against human cytochrome P450C24A1 (CYP24A1) hydroxylase. Inhibition ranged from IC50 0.3–72 μM compared with the standard ketoconazole IC50 0.52 μM, with the styryl derivative (11c) displaying enhanced activity (IC50 = 0.3 μM) compared with the standard, providing a useful preliminary lead for drug development.

We also recommend Trading Suppliers and Manufacturers of Benzamide, 4-ethyl-N-(1-phenylethyl)- (cas 116368-37-7). Pls Click Website Link as below: cas 116368-37-7 suppliers